Tetravalent hyperimmune Pseudomonas globulin G

Tetravalent hyperimmune Pseudomonas globulin G is a specialized intravenous immunoglobulin preparation enriched with antibodies targeting four major immunotypes of *Pseudomonas aeruginosa*. It is used as passive immunotherapy, particularly in patients with severe infections such as sepsis or bacteremia caused by *P. aeruginosa*, especially in high-risk populations like burn patients. The product contains high titers of IgG antibodies specific to the relevant *Pseudomonas* strains responsible for infection, aiming to boost host immunity and improve clinical outcomes. Its mechanism involves direct neutralization of bacterial antigens and enhancement of immune clearance through antibody-mediated processes[1]. This therapy has been associated with increased serum IgG levels and improved survival rates in clinical settings involving severe pseudomonal infections[1].

Other names

tetravalent hyperimmune Pseudomonas-intravenous immunoglobulin G